Best practices for machine learning in antibody discovery and development

Leonard Wossnig, Norbert Furtmann, Andrew Buchanan +2

Over the past 40 years, the discovery and development of therapeutic antibodies to treat disease has become common practice. However, as therapeutic antibody constructs are becomin…